Paul V. Benson, M.D., and Adrie J. C. Steyn, Ph.D. Extended research has been conducted to understand how Mycobacterium tuberculosis (Mtb) can remain in the body for many years without causing any ...

Using a mouse model that reflects the TB pathology of granuloma necrosis in humans, the DZIF research team demonstrated the remarkable ability of the new antibiotic BTZ-043 to efficiently penetrate, ...

What is TB? Tuberculosis, also known as TB, is a bacterial infection that primarily affects a person's lungs. Its symptoms vary widely depending on how the slow-growing mycobacterium that causes ...

Every year, 10 million people contract tuberculosis (TB). Around 1.5 million patients succumb to the disease caused by the bacterium Mycobacterium tuberculosis (Mtb). The novel antibiotic BTZ-043 ...

In the U.S., up to 13 million people of varying ages live with untreated and often undiagnosed latent TB infection (LTBI). Since tissue allografts contain live cells that are stored frozen and expire ...

The multidisciplinary symposium drew together leaders in the field of post-tuberculosis (TB) outcomes, including TB survivors, clinicians and TB program staff, researchers and stakeholders. Steyn ...

Original Article from The New England Journal of Medicine — The Teaching of Therapeutics — Tuberculosis among Cotton Mill Workers — Geographical Pathology — Acute Appendicitis and the ...

Every year, 10 million people contract tuberculosis (TB), a disease caused by the bacterium Mycobacterium tuberculosis (Mtb), and approximately 1.5 million patients succumb to the disease. Treatment ...